Echo Therapeutics Inc fka ECTE

[USOB]

@lintin
Playing devil's advocate. One would assume that AS has contacted all potential synergetic partners. Who knows, there may be some contenders. Abbott would be first choice. Competes with DexCom, Medtronic as well as numerous gene/immunoTX biopharmas. Echo's tCGM would fit in perfectly in the personalized medicine/pharmacogenetics/companion DX/clinical trial (LabCorp or Quest DX) spaces. If I was AS, I would make sure that dozens of meetings would be scheduled in order to partner with or to secure funding in joint venture opportunities. These areas are in infancy or semi-established phases that could mutually benefit from non-invasive clinical applications.